Search results for "Nitrofuran"

showing 10 items of 20 documents

CCDC 2121374: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione dimethyl sulfoxide solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2222724: Experimental Crystal Structure Determination

2022

Related Article: Lia̅na Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Be̅rziņš|2022|Cryst.Growth Des.|23|873|doi:10.1021/acs.cgd.2c01114

1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione dimethyl sulfoxide solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 922708: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione dimethyl sulfoxide solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 922164: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione dimethyl sulfoxide solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Re: Antimicrobial Resistance in More Than 100,000 Escherichia coli Isolates According to Culture Site and Patient Age, Gender, and Location

2011

ABSTRACT Escherichia coli and the antimicrobial pressure exerted on this microorganism can be modulated by factors dependent on the host. In this paper, we describe the distribution of antimicrobial resistance to amikacin, tobramycin, ampicillin, amoxicillin clavulanate, cefuroxime, cefoxitin, cefotaxime, imipenem, ciprofloxacin, fosfomycin, nitrofurantoin, and trimetoprim-sulfametoxazole in more than 100,000 E. coli isolates according to culture site and patient age, gender, and location. Bayesian inference was planned in all statistical analysis, and Markov chain Monte Carlo simulation was employed to estimate the model parameters. Our findings show the existence of a marked difference in…

AdultMaleCefotaximeAdolescentmedicine.drug_classUrologyAntibioticsCefotaximeDrug resistanceFosfomycinBiologymedicine.disease_causeEpidemiology and SurveillanceMicrobiologyYoung AdultAntibiotic resistanceFosfomycinCiprofloxacinPatient ageDrug Resistance Multiple BacterialEscherichia coliHumansMedicinePharmacology (medical)ChildAmikacinEscherichia coliEscherichia coli InfectionsAgedRetrospective StudiesAntibacterial agentAged 80 and overPharmacologybusiness.industryInfantMiddle AgedAntimicrobialAnti-Bacterial AgentsImipenemInfectious DiseasesNitrofurantoinAmikacinChild PreschoolTobramycinAmpicillinFemalebusinessmedicine.drugJournal of Urology
researchProduct

Nitrofurantoīna kristalizācija un iegūto kristālisko formu ietekmējošie faktori

2017

Nitrofurantoīna kristalizācija un iegūto kristālisko formu ietekmējošie faktori. Trimdale A., darba vadītājs Dr. Chem. Bērziņš A. Maģistra darbs, 60 lappuses, 18 attēli, 13 tabulas, 7 pielikumi, 52 literatūras avoti. Latviešu valodā. Darbā apkopota informācija par cietvielu kristāliskajām formām, kristalizācijas procesu, to ietekmējošajiem faktoriem un kontroles iespējām, kristālisko fāžu un šķīdumu pētījumos izmantotajām metodēm (rentgendifraktometriju, termisko analīzi, protonu kodolmagnētiskās rezonanses spektroskopiju, infrasarkano spektroskopiju, kvantu ķīmiskajiem aprēķiniem) un nitrofurantoīnu. Eksperimentālajā daļā veikta kristalizēšana no dažādiem tīriem organiskajiem šķīdinātājiem…

CRYSTALLIZATION CONTROLNITROFURANTOĪNSNITROFURANTOINASOCIĀTIKRISTALIZĀCIJAS KONTROLEĶīmija
researchProduct

Evaluation of Aspects Controlling Crystallization of Nitrofurantoin

2019

Nitrofurantoin was crystallized from multiple mixtures of water and organic solvents with and without additives to try to find and identify factors affecting phase obtained in crystallization and provide possible information on crystallization control. Obtained crystals were identified with powder X-ray diffractometry. Crystallization control possibilities were evaluated by using polymer additives and crystallization additives, by also using quantum chemical calculations to investigate the association of nitrofurantoin and additive molecules and calculate Gibbs energy of association.

Chemical engineeringMechanics of MaterialslawNitrofurantoinChemistryMechanical EngineeringmedicineGeneral Materials ScienceCrystallizationlaw.inventionmedicine.drugKey Engineering Materials
researchProduct

Reductive and oxidative metabolism of nitrofurantoin in rat liver.

1980

The elimination of nitrofurantoin was studied in the isolated rat liver using a recirculating hemoglobin-free perfusion system. The most rapid clearance of nitrofurantoin (0.1 mM) was found under hypoxia (8 ml/min) or anoxia (11 ml/min) indicating a fast and oxygen-sensitive reductive metabolism. The hepatic elimination of nitrofurantoin under anaerobic conditions apparently is not catalyzed by xanthine oxidase, aldehyde oxidase or cytochrome P-450 as judged from the lack of influence of the inhibitors (0.1 mM) allopurinol, menadione, metyrapone, α-naphthoflavone or of carbon monoxide (50%; v/v). Under aerobic conditions the hepatic clearance of nitrofurantoin is rather low (1 ml/min) indic…

MaleAllopurinolPharmacologyIn Vitro Techniquesurologic and male genital diseasesHydroxylationchemistry.chemical_compoundOxygen ConsumptionMenadionemedicineAnimalsXanthine oxidaseAldehyde oxidaseBiotransformationPharmacologyChemistryGeneral MedicineMetabolismfemale genital diseases and pregnancy complicationsRatsBiochemistryLiverNitrofurantoinNitrofurantoinMicrosomeOxidation-Reductionmedicine.drugSubcellular FractionsNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Kristalizācijā iegūtās nitrofurantoīna polimorfās formas kontroles iespēju un kristalizāciju raksturojošo parametru pētījums

2020

Literatūras apskatā apkopota informācija par dažādām kristāliskajām formām. Apskatīti polimorfu veidošanās mehānismi, to īpašības, ieguves un analīzes metodes. Veikts ieskats kristālu augšanā un sameklēta informācija par nitrofurantoīnu un tā formām. Darba eksperimentālajā daļā apskatīta piedevu ietekme uz nitrofurantoīna polimorfās formas veidošanos. Veikti nukleācijas, šķīšanas un datormodelēšanas eksperimenti.

PolimorfismsNitrofurantoīnsPiedevasDatormodelēšanaKristalizācijaĶīmija
researchProduct

CCDC 2122145: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

Space GroupCrystallographyCrystal SystemCrystal Structure1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione 14-dioxane solvate monohydrateCell ParametersExperimental 3D Coordinates
researchProduct